Epyrifenacil; Pesticide Tolerances
FDA established new pesticide tolerances for epyrifenacil on corn, rapeseed, soybean, and wheat. This directly impacts dietary supplement manufacturers using these crops as ingredients, as they must ensure raw materials comply with the new tolerance levels to avoid adulteration.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers using corn, rapeseed, soybean, or wheat derivatives. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately; enforcement begins upon publication (June 30, 2026).. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
New maximum residue limits (tolerances) for epyrifenacil on specified crops, effective immediately upon publication.
Who it affects
Supplement brands, contract manufacturers, private-label sellers, and ingredient suppliers using corn, rapeseed, soybean, or wheat derivatives.
What you must do
Verify that all incoming lots of affected crops meet the new tolerance levels; update supplier specifications and testing protocols.
Deadline
Immediately; enforcement begins upon publication (June 30, 2026).
Source: https://www.federalregister.gov/documents/2026/06/30/2026-13193/epyrifenacil-pesticide-tolerances
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- Warning Letters | FDA
- FDA Advisory No.2026-0735 || Public Health Warning on the Presence of Sildenafil Citrate in TURBO Maca and Clavo Huasca Dietary Supplement Capsules for Men with Lot Number 24TRB1102 - Food and Drug Administration - fda.gov.ph
- FDA Advisory No.2026-0162-A || Lifting the Advisory on the Registered Food Product LUXE SKIN BEAUTY TALKS L’ANNA Premium Oral Sunblock + Stem Cell Dietary Supplement “Public Health Warning Against the Purchase and Consumption of the Unregis - fda.gov.ph
- The Dietary Supplement Industry in the Time of Trump: Potential Opportunities and Pitfalls - Food and Drug Law Institute (FDLI)
- 60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - GlobeNewswire